BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CardioMag Imaging, Inc. (CMI) ('CardioMag' or the 'Company')


5/26/2006 10:38:53 AM

SCHENECTADY, N.Y., May 26 /PRNewswire/ -- CardioMag Imaging, Inc. (AIM: CMI) today hosted its first Annual General Meeting (AGM) since the Company was officially listed on the AIM market of the London Stock Exchange in December 2005. The meeting was held at its headquarters located at 450 Duane Avenue, Schenectady, New York.

At the AGM, shareholders were given an overview of the Company's activities, as well as progress achieved during 2005, including a status report on the facility expansion now underway.

All resolutions put to the AGM Shareholders meeting were duly passed.

Carl H. Rosner, President and CEO, made the following statement at 4pm EDT (9pm BST):

"We are very excited about bringing to the cardiac community an extremely sensitive device to measure basic cardiac function. The CMI system, approved by the FDA, is a totally safe, non-invasive, radiation-free, 10-15 minute test. The screening procedure is expected to dramatically improve patient outcomes, avoiding additional tests exposure to radiation, and to lower the overall cost of healthcare."

"The outlook in our full year statement included discussion of plans for the introduction and establishment of privately managed Heart Wellness Screening Centers. The Centers are expected to make it possible for an individual to be evaluated for confirmation of normal or abnormal heart function. The Company anticipates having the first Screening Center operational in the United States during the fourth quarter of the current fiscal year. "

CardioMag additionally announced the appointment of Dr. Afshin Abedi, Ph.D., as Vice President, responsible for the Company's clinical and regulatory activities.

The Annual Report for 2005 has been posted to shareholders and will be available to the public from the Company's offices in Schenectady, New York or from the offices of Salans at Millennium Bridge House, 2 Lambeth Hill, London EC4V 4AJ.

Safe Harbor Statement: CardioMag Imaging Inc. is a development stage company. The statements presented in this press release which are not historical facts are forward looking statements which involve various important assumptions, risks, uncertainties and other factors set forth here, including but not limited to, market acceptance by healthcare providers, obtaining FDA approval for future claims, insurance reimbursement policies, and growth of the market.

CardioMag Imaging, Inc.

CONTACT: Carl H. Rosner, Executive Chairman, CardioMag Imaging, Inc.,+1-518-381-1000, Ext. 63; Eric Burns, +011-44-1943-833990, or LisaBaderoon, +011-44-207-4665000, both of Buchanan Communications - UK



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES